Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Environ Entomol ; 44(4): 1201-9, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26314066

RESUMO

Bactericera cockerelli (Sulc) (Hemiptera: Triozidae) is a pest of potato (Solanum tuberosum L.) that vectors the bacterium that putatively causes zebra chip disease in potatoes, 'Candidatus Liberibacter solanacearum.' Zebra chip disease is managed by controlling populations of B. cockerelli in commercial potato fields. Lacking an integrated pest management strategy, growers have resorted to an intensive chemical control program that may be leading to insecticide-resistant B. cockerelli populations in south Texas and Mexico. To initiate the development of an integrated approach of controlling B. cockerelli, we used constant temperature studies, nonlinear and linear modeling, and field sampling data to determine and validate the degree day parameters for development of B. cockerelli infesting potato. Degree day model predictions for three different B. cockerelli life stages were tested against data collected from pesticide-free plots. The model was most accurate at predicting egg-to-egg and nymph-to-nymph peaks, with less accuracy in predicting adult-to-adult peaks. It is impractical to predict first occurrence of B. cockerelli in potato plantings as adults are present as soon cotyledons break through the soil. Therefore, we suggest integrating the degree day model into current B. cockerelli management practices using a two-phase method. Phase 1 occurs from potato planting through to the first peak in a B. cockerelli field population, which is managed using current practices. Phase 2 begins with the first B. cockerelli population peak and the degree day model is initiated to predict the subsequent population peaks, thus providing growers a tool to proactively manage this pest.


Assuntos
Hemípteros/fisiologia , Herbivoria , Controle de Insetos/métodos , Solanum tuberosum , Animais , Hemípteros/crescimento & desenvolvimento , Modelos Biológicos , Ninfa/crescimento & desenvolvimento , Ninfa/fisiologia , Óvulo/crescimento & desenvolvimento , Óvulo/fisiologia , Reprodutibilidade dos Testes , Solanum tuberosum/crescimento & desenvolvimento , Temperatura
2.
Dtsch Med Wochenschr ; 139(38): 1889-94, 2014 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-25203549

RESUMO

Therapeutic Drug Monitoring (TDM) is based on drug-level control in biological matrices and serves as a diagnostic approach for individualization of pharmacotherapy and drug safety. Drug levels of antibiotics are distinctly influenced by comorbidity, physiological changes and various concomitant drugs in patients on intensive care units. Several factors should be taken into account for calculation of relevant pharmacokinetic parameters (elimination half-life, bioavailability, and clearance) to deduce a recommendation for dosage. TDM is a diagnostic standard for the individualization of polypharmcotherapy based on validated analytical methods (in particular LC-MS/MS and HPLC-methods) in order to optimize dosing and drug safety.


Assuntos
Antibacterianos/farmacocinética , Antibacterianos/uso terapêutico , Monitoramento de Medicamentos , Unidades de Terapia Intensiva , Sepse/sangue , Sepse/tratamento farmacológico , Choque Séptico/sangue , Choque Séptico/tratamento farmacológico , Acetamidas/farmacocinética , Acetamidas/uso terapêutico , Aminoglicosídeos/farmacocinética , Aminoglicosídeos/uso terapêutico , Disponibilidade Biológica , Relação Dose-Resposta a Droga , Quimioterapia Combinada , Fluoroquinolonas/farmacocinética , Fluoroquinolonas/uso terapêutico , Fidelidade a Diretrizes , Humanos , Linezolida , Taxa de Depuração Metabólica/fisiologia , Testes de Sensibilidade Microbiana , Oxazolidinonas/farmacocinética , Oxazolidinonas/uso terapêutico , Sepse/mortalidade , Choque Séptico/mortalidade , Teicoplanina/farmacocinética , Teicoplanina/uso terapêutico , Vancomicina/farmacocinética , Vancomicina/uso terapêutico , beta-Lactamas/farmacocinética , beta-Lactamas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA